List of AstraZeneca's Acquisitions
Here's the year on year acquisition history of AstraZeneca:
Year | # Acquisitions |
|---|---|
2026 | 1 |
2025 | 1 |
2024 | 2 |
2023 | 3 |
2022 | 2 |
2021 | 1 |
2020 | 1 |
2015 | 2 |
2014 | 1 |
2013 | 2 |
2012 | 2 |
2009 | 1 |
2007 | 2 |
2006 | 1 |
2005 | 1 |
Recent acquisitions by AstraZeneca
AstraZeneca's most recent acquisition - Modella is a Developer of artificial intelligence for biomedical imaging, enhancing diagnostic workflows, founded in 2024 and located in Boston. AstraZeneca acquired it in January 2026 for a price of $*****.
Here is the list of all acquisitions by AstraZeneca sorted by the latest acquisition date:
Acquired on | Acquired Company | Acquisition Price | Facilitators | Stake Acquired | Acquisition Multiple |
|---|---|---|---|---|---|
Jan 13, 2026 | g{xp | uy{t | 92 | 882 | |
Mar 17, 2025 | ixsa | lkty | 36 | 264 | |
Mar 19, 2024 | krcn | feey | 12 | 258 | |
Mar 14, 2024 | h{h{ | wbei | 32 | 522 | |
Dec 26, 2023 | rsyu | rkbv | 75 | 666 |
View the full list of acquisitions
Sign Up for FreeNews related to AstraZeneca's acquisitions
Media has covered AstraZeneca for a total of 275 events in the last 1 year, 45 of them have been about acquisition activity.
•
Orpathys plus Tagrisso shows survival benefit in lung cancerPharmaTimes•Aug 19, 2026•AstraZeneca, Tagrisso
•
AstraZeneca in Talks to Acquire Bristol Myers Squibb for $131 BillionCaproasia•Aug 08, 2026•Bristol-Myers Squibb, AstraZeneca
•
CSPC and AstraZeneca Form Joint Venture for Biologics Manufacturing PlantChina Daily•Aug 05, 2026•AstraZeneca, Cspc, com.cn
•
SOPHiA GENETICS Reports Second Quarter 2026 ResultsPR Newswire•Aug 04, 2026•Sophia Genetics, AstraZeneca
•
AstraZeneca in Talks for Potential $400 Billion Megadeal with Bristol Myers SquibbThe Business Times•Aug 03, 2026•Bristol-Myers Squibb, AstraZeneca, National Grid, Merck and 5 others
•
•
AstraZeneca Acquires Global Rights to Lung Cancer Drug Zegfrovy from Dizal Pharma for Up to $1.5 BillionShareprices•Jul 14, 2026•AstraZeneca, Dizal Pharma, DIZAL, com.cn and 1 other
•
AstraZeneca to pay $200M upfront for Sino Biopharmaceutical’s COPD drug license dealSeeking Alpha•Jul 08, 2026•Sino Biopharmaceutical, AstraZeneca, UCB
•
Helix and AstraZeneca Forge Multi-Year Agreement for Genomic Research in Drug DiscoveryPR Newswire•Jul 07, 2026•Helix, AstraZeneca
•
